LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Clinical trials for LEFT VENTRICULAR SYSTOLIC DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new LEFT VENTRICULAR SYSTOLIC DYSFUNCTION trials appear
Sign up with your email to follow new studies for LEFT VENTRICULAR SYSTOLIC DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could this pill help kids with heart failure?
Disease control Recruiting nowThis study tests a medicine called vericiguat in children with heart failure caused by a weak left heart pump. About 342 kids from 1 month to 18 years old will take either vericiguat or a placebo for 16 weeks. The goal is to see if the medicine lowers a heart stress marker (NT-pr…
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 03:26 UTC
-
New hope for kids with heart failure: phase 3 trial begins
Disease control Recruiting nowThis study tests a drug called finerenone in children aged 6 months to 18 years who have heart failure and a weakened heart pump. The drug aims to reduce heart stress and improve function. About 111 children will receive either finerenone or a placebo for 3 months, alongside thei…
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
Iron pill may boost energy in heart failure patients
Symptom relief Recruiting nowThis study tests whether a special oral iron supplement (sucrosomial iron) can improve exercise ability and quality of life in people with chronic heart failure who also have low iron levels. About 60 participants will receive either the iron supplement or a placebo for several w…
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Phase: PHASE4 • Sponsor: Raffaele De Caterina • Aim: Symptom relief
Last updated May 18, 2026 12:08 UTC
-
Heart imaging study aims to spot hidden risks after valve surgery
Knowledge-focused Recruiting nowThis pilot study at Mayo Clinic will test whether combining cardiac CT and MRI can better predict which patients with severe mitral regurgitation are at risk for developing heart muscle weakness after valve repair surgery. The goal is to see if this approach is feasible for a lar…
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 03:33 UTC